LAUREN BOTELHO: Open Payments
NPI 1346600475 · SOUTHBOROUGH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,503 in 97 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $725 · 2025 $2,503
Food & beverage: $2,503
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $478 |
| ABBVIE INC. | 21 | $401 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $279 |
| Janssen Biotech, Inc. | 7 | $268 |
| Madrigal Pharmaceuticals | 6 | $166 |
| Regeneron Healthcare Solutions, Inc. | 5 | $148 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Ardelyx, Inc. | 6 | $112 |
| GENZYME CORPORATION | 4 | $109 |
| PFIZER INC. | 5 | $96 |
Products named: ENTYVIO, TREMFYA, DUPIXENT, XIFAXAN, REZDIFFRA, CREON, VOQUEZNA, RINVOQ.
Industry payments across MA — which companies pay providers there.
